White-coat hypertension and normotension in the league of hypertension of the Hospital das Clínicas, FMUSP. Prevalence, clinical and demographic characteristics;Efeito hipertensão e normotensao do avental branco na liga de hipertensão do Hospital das Clínicas, FMUSP. Prevalência, características clínicas e demográficas

Arquivos Brasileiros de Cardiologia

Volumn 80, Issue 2, 2003, Pages 117-126

  Segre, Carlos A ^a   Ueno, Rubens K ^a   Warde, Karim R J ^a   Accorsi, Tarso A D ^a   Miname, Márcio H ^a   Chi, Chang K ^a   Pierin, Angela M G ^a   Mion Jr , Décio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

White coat effect; White coat hypertension; White coat normotension

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BRAZIL; DIASTOLIC BLOOD PRESSURE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; GENDER; HEART LEFT VENTRICLE WALL; HUMAN; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; OSCILLOMETRY; PREVALENCE; SYSTOLIC BLOOD PRESSURE; WAKEFULNESS; WHITE COAT HYPERTENSION;

EID: 0037300361     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0066-782X2003000200001     Document Type: Article

References (35)

1. Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension 2000; 35: 844-51.
2. Verdecchia P, Clement D, Fagard R, Palatini P, Parati G. Blood Pressure Monitoring. Task Force III: Target-organ damage, morbidity and mortality. Blood Press Monit 1999; 4: 303-17.
3. Staessen JA, Beilin L, Parati G, Waeber B, White W. Task Force IV: Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 consensus conference on ambulatory blood pressure monitoring. Blood Press Monit 1999; 4: 319-31.
4. Pickering TG, Coats A, Mallion JM, Mancia G, Verdecchia P. Blood Pressure Monitoring. Task Force V: White Coat Hypertension. Blood Press Monit 1999; 4: 333-41.
5. III Diretrizes para o uso da monitorização ambulatorial da pressão arterial. I Diretrizes para o uso da monitorização residencial da pressão arterial. Rev Bras Hipertensão 2001; 8: 143-55.
6. Myers GM, Reeves RA. White coat effect in treated hypertensive patients: sex differences. J Hum Hypertens 1995; 9: 729-33.
7. Parati G, Omboni S, Staeesen J, et al. Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the "white-coat" effect. J Hypertens 1998; 16: 23-9.
8. Lantelme P, Milon H, Vernet M, Gayet C. Difference between office and ambulatory blood pressure or real white coat effect: does it matter in term of prognosis? J Hypertens 2000; 18: 383-9.
9. Parati G, Redon J. Direct and surrogate measures of the whitecoat effect: methodological aspects and clinical relevance. J Hypertens 2000; 18: 379-82.
10. Imai Y. Prognostic significance of ambulatory blood pressure. Blood Press Monit 1999; 4: 249-56.
11. Schrader J, Luders L, Zuchner C, Herbold M, Schrandt G. Practice vs ambulatory blood pressure measurement under treatment with Ramipril (PLUR Study): a randomized, prospective long term study to evaluate the benefits of ABPM in patients on antihypertensive treatment. J Hum Hypertens 2000; 14: 435-40.
12. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure - an independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793-801.
13. Gosse P, Promax H, Durandet P, Clementy J. 'White Coat' hypertension: no harm for the heart. Hypertension 1993; 22: 766-70.
14. Cavallini MC, Roman MJ, Pickering TG. 'Is White Coat' hypertension associared with arterial disease or left ventricular hypertrophy?" Hypertension 1995; 26: 413-9.
15. Pierdomenico SD, Mezetti A, Lapenna D, et al. 'White Coat' hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care. Eur Heart J 1995; 16: 692-7.
16. Verdecchia P, Schillaci G, Borgioni C, et al. White coat hypertension and white coat effect: similarities and differences. Am J Hypertens 1995; 8: 790-8.
17. Manning G, Rushton L, Millar-Craig MW. Clinical implications of white coat hypertension: an ambulatory blood pressure monitoring study. J Hum Hypertens 1999; 13: 817-22.
18. Pickering TG, et al. How Common is White Coat hypertension? JAMA 1998; 259: 228-55.
19. Khoury S, Yarows SA, O'Brien TK, Sowers JR. Ambulatory blood pressure monitoring in a non-academic setting: effects of age and Sex. Am J Hypertens 1992; 5: 616-23.
20. Staessen JA, O'brien E, Atkins N, Amery AK. Short report; ambulatory blood pressure in normotensive compared with hypertensive subjects. J Hypertens 1993; 11: 1289-97.
21. Siegel WC, Blumenthal JA, Divine G. Physiological, psychological and behavioral factors and white coat hypertension. Hypertension 1990; 16: 140-6.
22. Ravogli A, Trozzi S, Vilani A, et al. Early 24 hour blood pressure elevation in normotensive subjects with parenteral hypertension. Hypertension 1990; 16: 491-7.
23. Julius S, Meyia A, Jones K, et al. White coat vs sustained borderline hypertension in Tecumseh, Michigan. Hypertension 1990; 16: 671-3.
24. Jamerson KA. Effect of home blood pressure and gender on estimates of the familial aggregation of blood pressure. Hypertension 1992; 20: 314-418.
25. Hoegholm A, Bang LE, Kristensen KS, et al. Microalbuminuriaen 411 untreated individuals with established hypertension, white coat and normotension. Hypertension 1994; 24: 101-5.
26. Weber MA, Neritel JN, Smith DHG, Graettinger WF. Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation 1994; 90: 2291-8.
27. Khattar SR, Senior R, Lahiri A. Cardiovascular outcome in White Coat versus sustained mild hypertension: a 10-year follow-up study. Circulation 1998; 98: 1892-7.
28. Verdecchia P. White-coat hypertension in adults and children. Blood Press Monit 1999; 4: 175-9.
29. Gualdiero P, Nieubauer J, Addison C, Clark SJ, Coats AJ. Clinical features, anthropometric characteristics, and racial influences on the "white coat effect" in a single center cohort of 1553 consecutive subjects undergoing routine ambulatory blood pressure monitoring. Blood Press Monit 2000; 5: 53-7.
30. Selenta C, Hogan B, Linden W. How often do office blood pressure measurements fail to identify true hypertension? An exploration of white-coat normotension. Arch Fam Med 2000; 9:533-40.
31. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 1999; 131: 564-72.
32. Pierdomenico DS, Lapenna D, Guglielmi MD, et al. Target organ status and serum lipids in patients with white coat hypertension. Hypertension 1995; 26: 801-7.
33. Kuwajima I, et al. Pseudohypertension in the elderly. J Hypertens 1990; 8: 429-32.
34. Verdecchia P, Schillaci G, Boldrini F, et al. Variability between current definitions of 'normal' ambulatory blood pressure: implications in the assessment of white coat hypertension. Hypertension 1992; 20: 555-62.
35. Prattichizzo FA, Galetta F. L' "effetto camice bianco" sulla pressione arteriosa. Minerva Cardioangiol 1996; 44: 539-43.